ARTICLE SUMMARY:
A spinout of the Wellcome Trust Sanger Institute, Congenica aims to identify the causes of undiagnosed genetic diseases using state-of-the-art bioinformatics combined with its scientific founders’ deep expertise to maximize the clinical utility of next-gen sequencing.
The promise of human genome sequencing has grown exponentially in recent years, enabling its use in an increasing number of clinical applications, including diagnosis of rare diseases.
